Lori Hazlehurst
7Patents
3h-index
8Co-inventors
46Inventor score
Filing activity: Nov 4, 2004 → Jun 5, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7632814B2 | HYD1 peptides as anti-cancer agents | Chemistry; Metallurgy | 11 | Active |
| US8853149B2 | Integrin interaction inhibitors for the treatment of cancer | Human Necessities | 6 | Active |
| US8227434B1 | Materials and methods for treating oncological disorders | Chemistry; Metallurgy | 6 | Active |
| US10011635B2 | Cyclic peptide conjugates and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10059740B2 | Integrin interaction inhibitors for the treatment of cancer | Human Necessities | 2 | Active |
| US11078235B2 | Cyclic peptide conjugates and methods of use | Chemistry; Metallurgy | 1 | Active |
| US12060438B2 | Cyclic peptide compounds and methods of use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.